Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)

Clinical trial NCT00358644 · COMPLETED

Trial details

NCT number: NCT00358644
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2005-03-01
Primary completion: 2008-02-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.